Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Bevacizumab and irinotecan treatment for progressive diffuse brainstem glioma: case report.

Bevacizumab and irinotecan treatment for progressive diffuse brainstem glioma: case report. J Neurooncol. 2009 Jul; 93(3):409-12.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.